| REVLIMID Celgene Corporation
78188450 25 Nov 2002 | on 12 Jun 2024
| pharmaceutical preparations, namely, cytokine inhibitory drugs; pharma... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system | | | BRISTOL MYERS SQUIBB Bristol-Myers Squibb Company
97249118 01 Feb 2022 | on 11 Jun 2024
| Providing medical and scientific research information in the field of ... Class 042 Class 042 Computer & Software Services & Scientific Services Health care services, namely, providing information to physicians, health care professionals and patients on the topic of health issues and health awareness; Health care services, namely, providing information relating to diagnostic, prophylactic, and therapeutic properties of pharmaceuticals to physicians, health care professionals and patients; Providing a website featuring educational information in the field of healthcare; Providing a website featuring educational information relating to diagnostic, prophylactic, and therapeutic properties of pharmaceutical preparations Class 044 Class 044 Medical, Beauty & Agricultural Services Providing medical and scientific research information in the field of pharmaceuticals to physicians, health care professionals and patients | | | VIDAZA Celgene Corporation
78138324 24 Jun 2002 | on 03 Jun 2024
| Pharmaceutical preparations for the treatment of blood disease and can... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of blood disease and cancer | | | REYATAZ Bristol-Myers Squibb Company
78131406 28 May 2002 | on 03 Jun 2024
| Pharmaceutical preparations for the treatment [ and prevention ] of [ ... Class 005 Class 005 Pharmaceutical Products In the statement, Column 1 lines 6, 7, 8, 9, and 10 "AND PREVENTION OF CARDIOVASCULAR DISEASES CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS STROKE CANCER INFLAMMATION AND INFLAMMATORY DISEASES RESPIRATORY AND" should be deleted. In the statement, Column 2 lines 1 and 2, "AUTO-IMMUNE DISEASES, ANTIBIOTICS" should be deleted. | | | VIDEX EC Bristol-Myers Squibb Company
78223415 10 Mar 2003 | on 30 Apr 2024
| antiviral pharmaceutical preparation Class 005 Class 005 Pharmaceutical Products antiviral pharmaceutical preparation | | | Logo Mark Bristol-Myers Squibb Company
86445200 05 Nov 2014 | on 25 Sep 2018
| Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Color is not claimed as a feature of the mark. | | | Logo Mark Celgene Corporation
87608501 14 Sep 2017 | on 26 Jun 2018 | pharmaceutical preparations for the treatment of leukemia, other cance... Class 005 Class 005 Pharmaceutical Products The color(s) black, yellow and orange is/are claimed as a feature of the mark. | | | C Celgene Corporation
78447755 08 Jul 2004 | on 29 Nov 2014
| custom synthesis of DNA to the order and specification of others; cust... Class 005 Class 005 Pharmaceutical Products custom synthesis of DNA to the order and specification of others; custom manufacturing services [, namely, manufacturing agrochemicals to the specification of others ] Class 040 Class 040 Treatment & Processing of Materials Services The mark consists of design in the shape of a "c". Class 042 Computer & Software Services & Scientific Services biological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriological culture media for medical use; medicinal and biological preparations for pharmaceutical, clinical or medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system | | | ABRAXANE ABRAXIS BIOSCIENCE, LLC
78415969 10 May 2004 | on 03 Nov 2014
| Pharmaceutical for the treatment of cancer Class 005 Class 005 Pharmaceutical Products Pharmaceutical for the treatment of cancer | | | SIGNAL Celgene Corporation
76572994 29 Jan 2004 | on 18 Oct 2014
| research, development and testing services for others in the fields of... Class 042 Class 042 Computer & Software Services & Scientific Services Color is not claimed as a feature of the mark. | | 
